Analyst Price Targets — BLUE
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 22, 2022 2:49 pm | Gena Wang | Barclays | $5.00 | $5.83 | Pulse 2.0 | Bluebird Bio (BLUE) Stock: $5 Target And Equal-Weight Rating |
| March 7, 2022 12:00 am | David Nierengarten | Wedbush | $6.48 | $2.88 | Pulse 2.0 | bluebird bio (BLUE) Stock: $10 Price Target And Neutral Rating |
| November 19, 2021 12:00 am | Cory Kasimov | J.P. Morgan | $14.00 | $10.70 | StreetInsider | bluebird bio (BLUE) PT Lowered to $14 at JPMorgan |
| November 12, 2021 12:00 am | Zhiqiang Shu | Berenberg Bank | $11.00 | $11.68 | StreetInsider | bluebird bio (BLUE) PT Lowered to $11 at Berenberg |
| November 8, 2021 12:00 am | Salveen Richter | Goldman Sachs | $10.00 | $10.70 | TheFly | Bluebird Bio (BLUE) downgraded to Sell from Neutral at Goldman Sachs |
| September 13, 2021 12:00 am | Joshua Schimmer | Evercore ISI | $25.00 | $11.84 | Investing | Evercore ISI Stick to Their Buy Rating for bluebird bio |
| August 10, 2021 12:00 am | John Newman | Canaccord Genuity | $20.00 | $12.97 | TheFly | Bluebird Bio downgraded to Hold from Buy at Canaccord |
| August 9, 2021 12:00 am | Benjamin Burnett | Stifel Nicolaus | $18.00 | $11.76 | TheFly | Bluebird Bio price target lowered to $18 from $31 at Stifel |
Latest News for BLUE
NEW YORK--(BUSINESS WIRE)---- $OWL #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Blue Owl Capital Inc. (NYSE: OWL) failed to manage Blue Owl in an acceptable manner, breaching their fiduciary duties to Blue Owl, and whether Blue Owl and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the…
LANCASTER, Pa. and RUTHERFORD, N.J.
TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Labrador Gold Corp. (TSX.V: LAB | FNR: 2N6) (“LabGold” or the “Corporation”) is pleased to announce that Institutional Shareholder Services Inc. (“ISS”), a leading global independent proxy advisory firm, has recommended that LabGold shareholders vote ONLY on the BLUE Form of Proxy and BLUE Voting Instruction Form (“ BLUE Proxy”) in line with LabGold's recommendations, in…
New York, New York--(Newsfile Corp. - January 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Blue Owl Capital Inc. (NYSE: OWL) between February 6, 2025 and November 16, 2025, inclusive (the "Class Period"), of the important February 2, 2026 lead plaintiff deadline. SO WHAT: If you purchased Blue Owl securities during the Class Period you may be entitled to…
NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Blue Owl Capital Inc. (NYSE: OWL) between February 6, 2025 and November 16, 2025, inclusive (the “Class Period”), of the important February 2, 2026 lead plaintiff deadline.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for BLUE.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.